1. Michaeli J, Mogie S, Perlberg S, Heiman S, Caine M. Emphysematous pyelonephritis. J Urol 1984; 131: 203-207
2. Evanroff GV, Thompson CS, Foley R, Weinman EJ. Spectrum of gas within the kidney. Emphysematous pyelonephritis and emphysematous pyelitis. Am J Med 1987; 83:149-154.
3. Huang JJ, Tseng CC. Emphysematous pyelonephritis: Clinicoradiologicalclasasification, management, prognosis and pathogenesis. Arch Intern Med 2000; 160:797-805.
4. Ubee SS, McGlynn L, Fordham M. Emphysematous pyelonephritis. BJU Int 2011;107(9):1474-8
5. Flores G, Nellen H, Magaña F, Calleja J. Acute bilateral emphysematous pyelonephritis successfully managed by medical therapy alone: A case report and review of the literature. BMC nephrol. 2002; 3(1):4.
6. Sharma PK, Sharma R,  Vijay MK, Tiwari P, Goel A,  Kundu AK, Emphysematous pyelonephritis: Our experience with conservative management in 14 cases. Urol Ann. 2013;5(3): 157–162.
7. Laway BA, Bhat MA,  Bashir MI, Ganie MA,  Mir SA, and  Daga RA. Conservative management of emphysematous pyelonephritis. Indian J EndocrinolMetab. 2012;16(2): 303–305
8. Khade AL, Lad SK, Shah VB. Pathology of emphysematous pyelonephritis: A study of 11 cases. Med J DY PatilUniv 2016;9:722-6
9. JJ Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med 2000; 160:797–805.
10. Stein JP, Spitz A. Bilateral emphysematous pyelonephritis: a case report and review of the literature. Urology. 1996;47(1):129–134
11. Lu YC, Hong JH, Chiang BJ, Pong YH, Hsueh PR, Huang CY, Pu YS. Recommended Initial antimicrobial therapy for emphysematous pyelonephritis: 51 cases and 14 year experience of a tertiary referral center. Medicine 2016; 95:e3573.
12. Sultana SR, McNeille SA, Phillips G, Byrne D. Candidal Urinary tract infection as a cause of pneumaturia. J R CollSurgEdinb 1998; 43:198-199.
13. Ahmad M, Dakshinamurty KV. Emphysematous renal tract disease due to aspergillusfumigatis. J Assoc Physicians India 2004; 52:495-497.
14. Tang HJ, Li CM, Yen MYet al. Clinical characteristics of emphysematous pyelonephritis.J MicrobiolImmunol Infect. 2001;34(2):125-30.
15. Khaira A, Gupta A, Rana DS, Gupta A, Bhalla A, Khullar D. Gupta A, Bhalla A, Khullar D. Retrospective analysis of clinical profile, prognostic factors and outcome of 19patients of emphysematous pyelonephritis. IntUrolNephrol 2009;41:951-66.
16. Rafailidis,V, Karadimou V, Liouliakis C,Kougioumtzoglou D. Emphysematous pyelonephritis: a case report. Hippokratia. 2013 Oct-Dec; 17(4): 373–375.
17. Wan YL, Lo SK, Bullard MJ, Chang PL, Lee TY. Predictors of outcome
18. in emphysematous pyelonephritis. J Urol. 1998; 159(2):369-73.
19. . Lu YC, Chiang BJ, Pong YH, Huang KH, Hsueh PR, Huang CY, et al. Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis. BMC Infect Dis. 2014; 14:418.
20. Lotfali E, Aboighasemi S, Gatmirimotahhari FS, Alizadeh M, Arab-Mazar Z. Complicated bilateral fungal emphysematous pyelonephritis in a 55 year old diabetic female: A case report and review of literature. Curr Med Mycol 2018;4(2):32-3

FULL TEXT in - | page 61-66